"weight-loss injections" have become one of the most talked-about topics in the world of weight and metabolism. Behind this name stands a family of peptides — agonists of the GLP-1 receptor and beyond. Here we explain the scientific background: what they are, how they are studied to act, and the difference between Ozempic, Mounjaro and Retatrutide.
The information in this article is for educational purposes only and does not constitute medical advice or recommendation, nor does it call for the use of any compounds. All products on the site are intended for research only and are not intended for human or veterinary use.
What are "weight-loss injections"?
The term refers mainly to a family of compounds that mimic hormones of the digestive system, chief among them agonists of the receptor GLP-1. They were developed and studied in the context of appetite regulation and blood sugar levels.
How does it work? The mechanism in brief
The hormone GLP-1 is involved in the feeling of satiety, in slowing gastric emptying and in blood sugar regulation. Compounds that mimic it have been examined for their effect on appetite and energy balance. Some of the newer compounds act on more than one pathway simultaneously.
The family: from Semaglutide to Retatrutide
- Semaglutide — a single GLP-1 agonist. Known by the brand names Ozempic andWegovy.
- Tirzepatide — a dual agonist (GLP-1 + GIP). Known by the brand name Mounjaro.
- Retatrutide — a triple agonist (GLP-1 + GIP + Glucagon), still in the research stage. full guide here.
And what about "fat burning"?
The idea of increased energy expenditure is mainly linked to the Glucagon pathway, which has been examined in newer compounds such as Retatrutide. It is important to remember: this is an area of active research, and the reported results were achieved in controlled clinical trials and under supervision — not as a "magic solution".
Regulatory status and safety
Some of the compounds (such as Semaglutide and Tirzepatide) are approved for supervised medical use in various countries, while others (such as Retatrutide) are still investigational. Compounds sold for research purposes are not intended for human use. For any decision regarding weight management, you should consult a licensed physician.
Frequently asked questions
What is the difference between Ozempic and Mounjaro?
The number of receptors: Ozempic (Semaglutide) acts on one receptor, Mounjaro (Tirzepatide) on two.
What is the newest in the field?
Retatrutide — a triple agonist that is in research. read about it in the full guide.
For more information about the research compounds, go tothe shop and to the FAQ page.
The information in this article is general and for educational purposes only and does not constitute medical advice. The products on the site are intended for research only and are not intended for human or veterinary use.
